Cyclic guanosine 3′3′ monophosphate concentrations in pre-eclampsia: Effects of hydralazine

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 1, 1996, Pages 33-38

  López Jaramillo, Patricio ^a   Narváez, Marcelo ^a   Calle, Andrés ^a   Rivera, José ^a   Jácome, Patricio ^a   Ruano, César ^a   Nava, Eduardo ^b  

^a Hospital Gineco Obstetrico Isidro Ayora   (Ecuador)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; HYDRALAZINE; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; URINALYSIS;

ADULT; ARGININE; BIRTH WEIGHT; BLOOD PRESSURE; CYCLIC GMP; FEMALE; HUMANS; HYDRALAZINE; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; VASODILATOR AGENTS;

EID: 0030050090     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09512.x     Document Type: Article

References (35)

1. Bader ME, Bader RA. Cardiovascular hemodynamics in pregnancy and labor. Clin Obstet Gynecol 1968; 11: 924-939.
2. Gant NF, Daley GL, Chand S, et al. A study of angiotensin I1 pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682-2689.
3. MacGillivray I. Pre-eclampsia. The Hypertensive Disease of Pregnancy. London : Saunders, 1983.
4. López-Jaramillo P, Narváez M, Félix C, et al. Decreased nitric oxide synthesis in Andean ecuddorian women with pregnancy-induced hypertension. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA, editors. The Biology of Nitric Oxide, Volume 1. London : Portland Press. 1992: 376-379.
5. Moncada S, Higgs EA, Hodson HF, et al. The L-arginine: nitric oxide pathway. J Cardiovasc Pharmacol 1991; 17 (3 Suppl): S1-S9.
6. López-Jaramillo P, Narváez M, Weigel M, Yépez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andean population. Br J Obstet Gynaecol 1989; 96: 648-655.
7. López-Jaramillo P, Narváez M, Félix C, López A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet 1990; 335: 293.
8. Vallance P, Leone AM, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide in chronic renal failure. Lancet 1992; 339: 572-575.
9. Kopp L, Paradiz G, Tucci JR. Urinary excretion of cyclic 3′,5′-adenosine monophosphate and cyclic 3′,5′-guanosine mono-phosphate during and after pregnancy. J Clin Endocrinol Metah 1977; 44: 590-594.
10. Broadus AE, Hardman JG, Kaminsky NI, et al. Extracellular cyclic nucleotides. Ann NY Acad Sci 1971; 185: 50-66.
11. Gerzer R, Witzgall H, Tremblay J, et al. Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man. J Clin Endocrinol Metab 1985; 61: 1217-1219.
12. Lincoln TM, Cornwell TL. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 1991; 28: 129-137.
13. − cotransport in vascular smooth cells. J Biol Chem 1986; 261: 1546-1548.
14. Stegeers E, Van Lakwijk H, Fast J, et al. Atrial natriuretic peptide and atrial size during normal pregnancy. Br J Obstet Gynaecol 1991; 98: 202.
15. Malatino L, Stancanelli B, Greco G, et al. Atrial natriuretic peptide levels in normal pregnancy and the puerperium. Med Sci Res 1988; 16: 1113.
16. Thomsen JK, Storm TL, Thamsborg G, et al. Atrial natriuretic peptide concentrations in pre-eclampsia. BMJ 1987; 294: 1508-1510.
17. Otsuki Y, Okamoto E, Iwata I, et al. Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxaemia. J Endocrinol 1987; 114: 325-328.
18. Fievet P, Fournier A, De Bold A, et al. Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism. Am J Hypertens 1988; 1: 16-21.
19. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol 1989; 113: 41-87.
20. Weiner CP, Lizasoain I, Baylis SA, et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Nut1 Acad Sci USA 1994; 91: 5212-5216.
21. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994; 171: 838-843.
22. Conrad KP, Vernier KA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol 1989: 257: R847-R853.
23. Conrad KP, Joffe GM, Kruszyna H, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEBJ 1993; 7: 566-571.
24. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169: 1316-1320.
25. Fickling SA, Williams D, Vallance P, et al. Plasma concentration of an endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993; 342: 242-243.
26. López-Jaramillo P, Yipez R, Narváez M, Gaibor M, Moscoso H, Corrado AP. Calcium metabolism in normal pregnancy and pregnancy-induced hypertension. J Bras Ginecol 1988; 98: 189-191.
27. Seely EW, Wood RJ, Brown EM, Graves SW. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab 1992; 74: 1436-1440.
28. 2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol 1990: 101: 489-493.
29. Bevan JA, Joyce EH. Calcium dependence of flow-induced dilation. Cooperation interaction with sodium. Hypertension 1993; 21: 16-21.
30. López-Jaramitlo P, Terin E, Moncada S. Calcium supplementation prevent pregnancy-induced hypertension by increasing the production of vascular nitric oxide. Med Hypotheses 1995; 45: 68-72.
31. Spokas EG, Folco G, Quilley J, et al. Endothelial mechanism in the vascular action of hydralazine. Hypotension 1983; 5 (I Suppl): I-107-I-111.
32. Mota-Filipe H, Castro M, Giao-T-Rico JM. The NO production is increased by hydralazine on the perfused rat hindquarters. Can J Physiol Pharmacol 1994; 72 (Suppl 1): 478.
33. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204.
34. Ferris TF. Pregnancy, preeclampsia, and the endothelial cell. N Engl J Med 1991; 325: 1439-1440.
35. Ignarro LJ, Burke TM, Wood KS, Wolin MS, Kadowitz PJ. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther 1984; 228: 682-690.